Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CQ Pharmaceutical Holding Co Total Current Liabilities Chart
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.
Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.
What does a Total Current Liabilities of ¥49,481 Mil mean?
CQ Pharmaceutical Holding Co (SZSE:000950) has a Total Current Liabilities of ¥49,481 Mil as of Jun. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for CQ Pharmaceutical Holding Co and its competitors.
Is CQ Pharmaceutical Holding Co's Total Current Liabilities too high?
CQ Pharmaceutical Holding Co's current Total Current Liabilities is ¥49,481 Mil. Overall, CQ Pharmaceutical Holding Co has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CQ Pharmaceutical Holding Co's Total Current Liabilities compare to MCK and COR?
CQ Pharmaceutical Holding Co's Total Current Liabilities of ¥49,481 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Medical Distribution company?
A good Total Current Liabilities depends on the Medical Distribution industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for CQ Pharmaceutical Holding Co and its competitors. CQ Pharmaceutical Holding Co's current Total Current Liabilities is ¥49,481 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CQ Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co (SZSE:000950) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.68, compared to a current price of ¥5.17 — trading 9% below its estimated fair value. The current Total Current Liabilities is ¥49,481 Mil. CQ Pharmaceutical Holding Co's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For CQ Pharmaceutical Holding Co (SZSE:000950), the current Total Current Liabilities is ¥49,481 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CQ Pharmaceutical Holding Co (SZSE:000950) Overvalued in 2026?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co stock appears to be undervalued.
The current stock price of ¥5.17 is trading 9% below its estimated GF Value™ of ¥5.68.
GuruFocus considers CQ Pharmaceutical Holding Co to be Fairly Valued.
Key valuation signals for SZSE:000950:
Total Current Liabilities: ¥49,481 Mil
GF Value™: ¥5.68 vs. price of ¥5.17 (9% below fair value)
No single metric tells the full story. See the SZSE:000950 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
77GF Score
Get the complete analysis for SZSE:000950
Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000950 has been successfully added to your 
